Correlation Between Broadcom and Cipher Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Broadcom and Cipher Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Broadcom and Cipher Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Broadcom and Cipher Pharmaceuticals, you can compare the effects of market volatilities on Broadcom and Cipher Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Broadcom with a short position of Cipher Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Broadcom and Cipher Pharmaceuticals.

Diversification Opportunities for Broadcom and Cipher Pharmaceuticals

-0.21

Correlation Coefficient

Broadcom  Cipher Pharmaceuticals

Very good diversification

The 3 months correlation between Broadcom and Cipher is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Broadcom and Cipher Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cipher Pharmaceuticals and Broadcom is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Broadcom are associated (or correlated) with Cipher Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cipher Pharmaceuticals has no effect on the direction of Broadcom i.e., Broadcom and Cipher Pharmaceuticals go up and down completely randomly.

Pair Corralation between Broadcom and Cipher Pharmaceuticals

Assuming the 90 days trading horizon Broadcom is expected to generate 0.81 times more return on investment than Cipher Pharmaceuticals. However, Broadcom is 1.24 times less risky than Cipher Pharmaceuticals. It trades about 0.34 of its potential returns per unit of risk. Cipher Pharmaceuticals is currently generating about 0.02 per unit of risk. If you would invest  4,522  in Broadcom on April 28, 2025 and sell it today you would earn a total of  2,300  from holding Broadcom or generate 50.86% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Broadcom  vs.  Cipher Pharmaceuticals

Broadcom

Risk-Adjusted Performance

Strong

Compared to the overall equity markets, risk-adjusted returns on investments in Broadcom are ranked lower than 26 (%) of all global equities and portfolios over the last 90 days. In spite of rather abnormal technical and fundamental indicators, Broadcom exhibited solid returns over the last few months and may actually be approaching a breakup point.

Cipher Pharmaceuticals

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Cipher Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy technical indicators, Cipher Pharmaceuticals is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Broadcom and Cipher Pharmaceuticals

The main advantage of trading using opposite Broadcom and Cipher Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Broadcom position performs unexpectedly, Cipher Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cipher Pharmaceuticals will offset losses from the drop in Cipher Pharmaceuticals' long position.

The idea behind Broadcom and Cipher Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.